{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:59:03Z","timestamp":1790431143344,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1378\/chest.13-1635","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T10:27:12Z","timestamp":1378376832000},"page":"1839-1847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Development of a Novel Composite Stroke and Bleeding Risk Score in Patients With Atrial Fibrillation"],"prefix":"10.1016","volume":"144","author":[{"given":"Gregory Y.H.","family":"Lip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre A.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Buller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Apostolakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1378\/chest.13-1635_bib1","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation\u2014developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"issue":"6","key":"10.1378\/chest.13-1635_bib2","first-page":"997","article-title":"Bleeding risk assessment and management in atrial fibrillation patients. Executive summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis","volume":"106","author":"Lip","year":"2011","journal-title":"Thromb Haemost"},{"issue":"suppl 1","key":"10.1378\/chest.13-1635_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1538-7836.2011.04302.x","article-title":"Stroke in atrial fibrillation: epidemiology and thromboprophylaxis","volume":"9","author":"Lip","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1378\/chest.13-1635_bib4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"9","key":"10.1378\/chest.13-1635_bib5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2012.06.019","volume":"60","author":"Apostolakis","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1378\/chest.13-1635_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1378\/chest.12-0608","article-title":"Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a \u201creal-world\u201d population with atrial fibrillation receiving anticoagulant therapy","volume":"143","author":"Rold\u00e1n","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.13-1635_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/CIRCEP.112.972869","article-title":"Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project","volume":"5","author":"Lip","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1378\/chest.13-1635_bib8","unstructured":"Lip GY, Lin HJ, Hsu HC, et al. Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: The Chin-Shan Community Cohort Study [published online ahead of print January 18, 2013]. Int J Cardiol. doi:pii:S0167-5273(12)01705-6."},{"issue":"1","key":"10.1378\/chest.13-1635_bib9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ijcard.2012.09.148","article-title":"Comparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a non-atrial fibrillation population: The Chin-Shan Community Cohort Study","volume":"168","author":"Lip","year":"2013","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1378\/chest.13-1635_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1160\/TH11-12-0827","article-title":"The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER)","volume":"108","author":"Omran","year":"2012","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1378\/chest.13-1635_bib11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4244\/EIJV8I6A105","article-title":"Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score","volume":"8","author":"Smith","year":"2012","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1378\/chest.13-1635_bib12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCEP.111.967000","article-title":"Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation","volume":"5","author":"Gallego","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"16","key":"10.1378\/chest.13-1635_bib13","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/01.CIR.0000118472.77237.FA","article-title":"Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"109","author":"Steinberg","year":"2004","journal-title":"Circulation"},{"issue":"23","key":"10.1378\/chest.13-1635_bib14","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"issue":"9609","key":"10.1378\/chest.13-1635_bib15","first-page":"315","article-title":"Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial [published correction appears in Lancet. 2008;372(9655):2022]","volume":"371","author":"Bousser","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1378\/chest.13-1635_bib16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCULATIONAHA.111.055970","article-title":"Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial","volume":"125","author":"Hohnloser","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1378\/chest.13-1635_bib17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"11","key":"10.1378\/chest.13-1635_bib18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.0b013e318287281b","article-title":"CHADS2, CHA2S2DS2-VASc, and long-term stroke outcome in patients without atrial fibrillation","volume":"80","author":"Ntaios","year":"2013","journal-title":"Neurology"},{"issue":"21","key":"10.1378\/chest.13-1635_bib19","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1378\/chest.13-1635_bib20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.thromres.2007.05.014","article-title":"Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score","volume":"121","author":"Poli","year":"2007","journal-title":"Thromb Res"},{"issue":"3","key":"10.1378\/chest.13-1635_bib21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"issue":"2","key":"10.1378\/chest.13-1635_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCEP.111.966713","article-title":"Reliable identification of \u201ctruly low\u201d thromboembolic risk in patients initially diagnosed with \u201clone\u201d atrial fibrillation: the Belgrade atrial fibrillation study","volume":"5","author":"Potpara","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"10.1378\/chest.13-1635_bib23","first-page":"739","article-title":"Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a \u2018real world' nationwide cohort study","volume":"106","author":"Olesen","year":"2011","journal-title":"Thromb Haemost"},{"issue":"19","key":"10.1378\/chest.13-1635_bib24","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study","volume":"125","author":"Friberg","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1378\/chest.13-1635_bib25","first-page":"125","article-title":"Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate\/rhythm control","volume":"28","author":"Skanes","year":"2012","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1378\/chest.13-1635_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jacc.2011.08.071","article-title":"The ATRIA risk scheme to predict warfarin-associated hemorrhage not ready for clinical use","volume":"59","author":"Olesen","year":"2012","journal-title":"J Am Coll Cardiol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215486945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215486945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:22:25Z","timestamp":1757920945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215486945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0012369215486945"],"URL":"https:\/\/doi.org\/10.1378\/chest.13-1635","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a Novel Composite Stroke and Bleeding Risk Score in Patients With Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.13-1635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}